Ad-hoc | 2 November 2004 07:27

Fresenius Group – First nine months 2004

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Fresenius Group – First nine months 2004 Fresenius continues successful revenue and earnings development, raises earnings outlook Fresenius Medical Care and Fresenius Kabi continued to exceed their earnings targets. Revenues and earnings of Fresenius ProServe are within expectations for 2004. Sales in the first nine months of 2004 rose 8 % in constant currency and 3 % at actual exchange rates to EUR 5,399 million (Q1-Q3 2003: EUR 5,254 million). Group EBIT rose 13 % in constant currency and 6 % at actual exchange rates to EUR 628 million (Q1-Q3 2003: EUR 590 million). Net income rose 26 % in constant currency and 19 % at actual exchange rates to EUR 125 million (Q1-Q3 2003: EUR 105 million). Earnings per ordinary share rose to EUR 3.04 (Q1-Q3 2003: EUR 2.55). Earnings per preference share rose to EUR 3.06 (Q1-Q3 2003: EUR 2.57). This represents an increase of 19 %. Based on these excellent results, Fresenius Group raises its earnings outlook for the full year 2004: Net income is expected to grow approximately 35 % in constant currency. Previously, the Company expected net income to increase at approximately 30 %. Fresenius expects 2004 sales growth in constant currency in the high single-digit range. Sales and earnings growth is expected in all business segments. The Management Board Bad Homburg v.d.H., November 2, 2004 end of ad-hoc-announcement (c)DGAP 02.11.2004 ——————————————————————————– WKN: 578563; ISIN: DE0005785638; Index: MDAX Listed: Amtlicher Markt in Düsseldorf, Frankfurt (Prime Standard) und München; Freiverkehr in Berlin-Bremen, Hamburg und Stuttgart 020727 Nov 04